Literature DB >> 21894439

Expression patterns of the tumor suppressor PDCD4 and correlation with β-catenin expression in gastric cancers.

Takashi Kakimoto1, Ryosuke Shiraishi, Ryuichi Iwakiri, Kazuma Fujimoto, Hirokazu Takahashi, Hiroshi Hamajima, Toshihiko Mizuta, Hiroyuki Ideguchi, Shuji Toda, Yoshihiko Kitajima, Iwata Ozaki, Sachiko Matsuhashi.   

Abstract

The expression patterns of PDCD4, a tumor suppressor, and β-catenin were immunohistologically investigated in gastric carcinoma tissues. In normal gastric tissues, PDCD4 was strongly expressed in the cell nuclei, but weakly expressed in the cytoplasm. In gastric adenocarcinoma tissues, nuclear PDCD4 expression was decreased, while cytoplasmic PDCD4 expression was unchanged or somewhat increased. In gastric signet ring cell carcinoma tissues, PDCD4 expression patterns were different from the expression patterns of the adenocarcinoma tissues, and PDCD4 was localized in the nuclei of the carcinoma cells as a belt in the middle of the epithelial layer. The nuclear localization of PDCD4 in the adenocarcinoma tissues was correlated with the membrane localization of β-catenin, the activation of which stimulates invasion of colon cancer cells. PDCD4 expression was correlated with β-catenin expression in gastric carcinoma cell lines, but not with E-cadherin, as the binding partner in the cell membrane.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21894439     DOI: 10.3892/or.2011.1450

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  8 in total

1.  Programmed cell death 4 mechanism of action: The model to be updated?

Authors:  Polina N Vikhreva; Svetlana V Kalinichenko; Igor V Korobko
Journal:  Cell Cycle       Date:  2017-08-30       Impact factor: 4.534

2.  The clinical association of programmed cell death protein 4 (PDCD4) with solid tumors and its prognostic significance: a meta-analysis.

Authors:  John Zeng Hong Li; Wei Gao; Wai-Kuen Ho; Wen Bin Lei; William Ignace Wei; Jimmy Yu-Wai Chan; Thian-Sze Wong
Journal:  Chin J Cancer       Date:  2016-11-16

Review 3.  Control Mechanisms of the Tumor Suppressor PDCD4: Expression and Functions.

Authors:  Sachiko Matsuhashi; M Manirujjaman; Hiroshi Hamajima; Iwata Ozaki
Journal:  Int J Mol Sci       Date:  2019-05-09       Impact factor: 5.923

4.  Celastrus orbiculatus Extract Reduces Stemness of Gastric Cancer Stem Cells by Targeting PDCD4 and EIF3H.

Authors:  Yao-Dong Zhu; He Ba; Jie Chen; Mei Zhang; Ping Li
Journal:  Integr Cancer Ther       Date:  2021 Jan-Dec       Impact factor: 3.279

5.  Disease progression role as well as the diagnostic and prognostic value of microRNA-21 in patients with cervical cancer: A systematic review and meta-analysis.

Authors:  Alemu Gebrie
Journal:  PLoS One       Date:  2022-07-27       Impact factor: 3.752

6.  CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence.

Authors:  K Hirata; H Suzuki; H Imaeda; J Matsuzaki; H Tsugawa; O Nagano; K Asakura; H Saya; T Hibi
Journal:  Br J Cancer       Date:  2013-06-18       Impact factor: 7.640

7.  PDCD4 Knockdown Induces Senescence in Hepatoma Cells by Up-Regulating the p21 Expression.

Authors:  Jing Guo; Iwata Ozaki; Jinghe Xia; Takuya Kuwashiro; Motoyasu Kojima; Hirokazu Takahashi; Kenji Ashida; Keizo Anzai; Sachiko Matsuhashi
Journal:  Front Oncol       Date:  2019-01-09       Impact factor: 6.244

8.  Clinical Significance of PDCD4 in Melanoma by Subcellular Expression and in Tumor-Associated Immune Cells.

Authors:  Thuy T Tran; Chetan K Rane; Christopher R Zito; Sarah A Weiss; Shlomit Jessel; Liliana Lucca; Benjamin Y Lu; Victor O Oria; Adebowale Adeniran; Veronica L Chiang; Sacit Bulent Omay; David A Hafler; Harriet M Kluger; Lucia B Jilaveanu
Journal:  Cancers (Basel)       Date:  2021-03-02       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.